EcoDrugPlus

Toll Like Receptor 9

Ensembl ID : ENSVVUG00000026842
Gene Symbol: TLR9
1 Cross references
82 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSVVUG00000019405
Gene Symbol: TGFBR1
3 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSVVUG00000019090
Gene Symbol: TRPA1
3 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSVVUG00000025528
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSVVUG00000000966
Gene Symbol: TSPO
3 Cross references
126 Possible Orthologues:

Transthyretin

Ensembl ID : ENSVVUG00000027365
Gene Symbol: TTR
3 Cross references
163 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSVVUG00000023982
Gene Symbol: TPH1
3 Cross references
255 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSVVUG00000025771
Gene Symbol: TUBA4A
4 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSVVUG00000016193
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSVVUG00000019054
Gene Symbol: TUBB2B
3 Cross references
182 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSVVUG00000004450
Gene Symbol: TUBB3
3 Cross references
135 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSVVUG00000029411
Gene Symbol: TUBB4B
3 Cross references
316 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).